DIN 02516322 — TEPMETKO 225 MG
TEPMETKO is a tablet of Tepotinib marketed by EMD SERONO, A DIVISION OF EMD INC., CANADA. The full Tepotinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02516322
- Brand name
- TEPMETKO
- Active ingredient
- Tepotinib
- Strength
- 225 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- EMD SERONO, A DIVISION OF EMD INC., CANADA
- Health Canada status
- MARKETED
- Drug class
- MET tyrosine kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.